交易 Greenwich LifeSciences, Inc. - GLSI CFD
新增到我的最愛- 摘要
- 曆史數據
- 活動
- 盈虧控制
- 資産負債表
- 現金流
交易條件
價差 | 0.23 | ||||||||
多頭倉位隔夜費用
多頭隔夜費用
前往平台 | -0.026179% | ||||||||
空頭倉位隔夜費用
空頭隔夜費用
前往平台 | 0.003957% | ||||||||
隔夜費時間 | 21:00 (UTC) | ||||||||
最小成交量 | 1 | ||||||||
貨幣 | USD | ||||||||
保證金 | 5% | ||||||||
股票交易 | United States of America | ||||||||
交易委員會 | 0% |
*Information provided by Capital.com
Greenwich Lifesciences Inc ESG Risk Ratings
High Medium Low Negligible
“D”分數表示相對 ESG 表現較差,公開報告重要 ESG 數據的透明度不足。
- 上週
- 上個月
- 去年
- 過去兩年
- 最大
- 每日
- 每週
- 每月
日期 | 拋售 | 自訂 | 變化 (%) | 打開 | 最高 | 最小 |
---|---|---|---|---|---|---|
Apr 19, 2024 | 12.05 | -0.67 | -5.27% | 12.72 | 13.03 | 11.98 |
Apr 18, 2024 | 12.88 | -0.11 | -0.85% | 12.99 | 13.99 | 12.64 |
Apr 17, 2024 | 13.08 | -0.91 | -6.50% | 13.99 | 14.40 | 12.36 |
Apr 16, 2024 | 14.51 | 0.75 | 5.45% | 13.76 | 14.59 | 13.76 |
Apr 15, 2024 | 14.17 | -1.19 | -7.75% | 15.36 | 15.55 | 13.67 |
Apr 12, 2024 | 15.56 | 0.04 | 0.26% | 15.52 | 16.22 | 14.98 |
Apr 11, 2024 | 15.79 | 0.16 | 1.02% | 15.63 | 16.11 | 15.48 |
Apr 10, 2024 | 15.65 | -0.62 | -3.81% | 16.27 | 16.47 | 15.29 |
Apr 9, 2024 | 16.44 | 0.20 | 1.23% | 16.24 | 17.04 | 16.23 |
Apr 8, 2024 | 16.29 | -0.73 | -4.29% | 17.02 | 17.29 | 16.09 |
Apr 5, 2024 | 17.18 | -0.32 | -1.83% | 17.50 | 17.71 | 17.00 |
Apr 4, 2024 | 17.65 | 0.12 | 0.68% | 17.53 | 18.09 | 17.42 |
Apr 3, 2024 | 17.70 | 0.02 | 0.11% | 17.68 | 18.28 | 17.50 |
Apr 2, 2024 | 17.41 | -0.98 | -5.33% | 18.39 | 18.39 | 17.26 |
Apr 1, 2024 | 19.02 | -0.96 | -4.80% | 19.98 | 20.08 | 17.10 |
Mar 28, 2024 | 19.71 | -0.13 | -0.66% | 19.84 | 20.28 | 19.35 |
Mar 27, 2024 | 19.98 | -0.26 | -1.28% | 20.24 | 21.24 | 19.84 |
Mar 26, 2024 | 20.29 | 0.71 | 3.63% | 19.58 | 20.66 | 19.46 |
Mar 25, 2024 | 19.21 | -0.46 | -2.34% | 19.67 | 19.73 | 19.18 |
Mar 22, 2024 | 19.60 | 0.61 | 3.21% | 18.99 | 20.22 | 18.98 |
Greenwich LifeSciences, Inc. Events
時間 (UTC) | 國家 | 事件 |
---|---|---|
Wednesday, May 22, 2024 | ||
時間 (UTC) 20:00 | 國家 US
| 事件 Q1 2024 Greenwich Lifesciences Inc Earnings Release Q1 2024 Greenwich Lifesciences Inc Earnings ReleaseForecast(預報) -返回 - |
Wednesday, August 21, 2024 | ||
時間 (UTC) 20:00 | 國家 US
| 事件 Q2 2024 Greenwich Lifesciences Inc Earnings Release Q2 2024 Greenwich Lifesciences Inc Earnings ReleaseForecast(預報) -返回 - |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
總收入 | 0 | 0 | 0 | 0 | 0 |
收入 | 0 | 0 | 0 | 0 | 0 |
總營業費用 | 8.04025 | 4.59794 | 1.86379 | 3.42531 | 1.68966 |
銷售/一般/行政費用,總計 | 1.56459 | 1.03843 | 0.80619 | 0.81889 | 0.41964 |
研究與開發 | 6.47567 | 3.55952 | 1.05761 | 2.60642 | 1.27002 |
營業收入 | -8.04025 | -4.59794 | -1.86379 | -3.42531 | -1.68966 |
稅前淨收入 | -7.82524 | -4.57058 | -1.86296 | -3.42531 | -1.68966 |
稅後淨收入 | -7.82524 | -4.57058 | -1.86296 | -3.42531 | -1.68966 |
未計算非常項目前的淨收益 | -7.82524 | -4.57058 | -1.86296 | -3.42531 | -1.68966 |
淨收入 | -7.82524 | -4.57058 | -1.86296 | -3.42531 | -1.68966 |
普通股股東可獲收益 (不含非經常性項目) | -7.82524 | -4.57058 | -1.86296 | -3.42531 | -1.68966 |
普通股股東可獲收益 (含非經常性項目) | -7.82524 | -4.57058 | -1.86296 | -3.42531 | -1.68966 |
攤薄淨收入 | -7.82524 | -4.57058 | -1.86296 | -3.42531 | -1.68966 |
攤薄後加權平均股 | 12.9138 | 12.9441 | 12.7035 | 11.9702 | 11.9702 |
扣除特別項目的每股攤薄盈利 | -0.60596 | -0.3531 | -0.14665 | -0.28615 | -0.14116 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | |||
每股正常攤薄盈利 | -0.60596 | -0.3531 | -0.14665 | -0.28615 | -0.14116 |
利息收入(費用),非經營淨值 | 0.21502 | 0.02737 | 0.00083 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
總收入 | 0 | 0 | 0 | 0 | 0 |
收入 | 0 | 0 | 0 | 0 | 0 |
總營業費用 | 2.50293 | 1.74783 | 2.24108 | 2.89468 | 2.38306 |
銷售/一般/行政費用,總計 | 0.34476 | 0.36826 | 0.41318 | 0.43658 | 0.65957 |
研究與開發 | 2.15817 | 1.37957 | 1.82791 | 2.4581 | 1.72349 |
營業收入 | -2.50293 | -1.74783 | -2.24108 | -2.89468 | -2.38306 |
利息收入(費用),非經營淨值 | 0.11114 | 0.11945 | 0.11618 | 0.10417 | 0.06404 |
稅前淨收入 | -2.39179 | -1.62837 | -2.1249 | -2.79051 | -2.31902 |
稅後淨收入 | -2.39179 | -1.62837 | -2.1249 | -2.79051 | -2.31902 |
未計算非常項目前的淨收益 | -2.39179 | -1.62837 | -2.1249 | -2.79051 | -2.31902 |
淨收入 | -2.39179 | -1.62837 | -2.1249 | -2.79051 | -2.31902 |
普通股股東可獲收益 (不含非經常性項目) | -2.39179 | -1.62837 | -2.1249 | -2.79051 | -2.31902 |
普通股股東可獲收益 (含非經常性項目) | -2.39179 | -1.62837 | -2.1249 | -2.79051 | -2.31902 |
攤薄淨收入 | -2.39179 | -1.62837 | -2.1249 | -2.79051 | -2.31902 |
攤薄後加權平均股 | 12.8482 | 12.8482 | 12.8482 | 12.4525 | 12.8235 |
扣除特別項目的每股攤薄盈利 | -0.18616 | -0.12674 | -0.16539 | -0.22409 | -0.18084 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常攤薄盈利 | -0.18616 | -0.12674 | -0.16539 | -0.22409 | -0.18084 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
流動資産總額 | 13.468 | 27.2043 | 28.6604 | 0.00684 | 0.0851 |
現金和短期投資 | 13.468 | 27.2043 | 28.6604 | 0.00684 | 0.0851 |
現金 | 13.468 | 27.2043 | 28.6604 | 0.00684 | 0.0851 |
總資産 | 13.477 | 27.2169 | 28.6766 | 0.02667 | 0.10855 |
無形資産,淨額 | 0.009 | 0.01262 | 0.01623 | 0.01984 | 0.02344 |
流動負債總額 | 0.26291 | 0.38517 | 1.04549 | 1.37709 | 0.7286 |
Payable/Accrued | 0.22085 | 0.22085 | 0.71097 | 0.73031 | 0.27756 |
預提費用 | 0.04206 | 0.16433 | 0.05937 | 0.01163 | 0.03089 |
應付票據/短期債務 | 0 | 0 | 0.27515 | 0.63515 | 0 |
長期債務的當前部分/資本租賃 | 0.42015 | ||||
負債總額 | 0.26291 | 0.38517 | 1.04549 | 1.37709 | 10.2286 |
長期債務總額 | 0 | 0 | 0 | 0 | 9.5 |
長期債務 | 0 | 9.5 | |||
股權 | 13.2141 | 26.8317 | 27.6311 | -1.35042 | -10.1201 |
Preferred Stock - Non Redeemable, Net | 0.00198 | 0.00198 | |||
普通股 | 0.01285 | 0.01315 | 0.0127 | 0.00846 | 0.0002 |
額外實收資本 | 54.674 | 60.4661 | 56.6954 | 25.8531 | 13.6664 |
留存收益(累計赤字) | -41.4728 | -33.6475 | -29.077 | -27.214 | -23.7887 |
總負債和股東權益 | 13.477 | 27.2169 | 28.6766 | 0.02667 | 0.10855 |
已發行普通股總數 | 12.8482 | 13.1478 | 12.7035 | 11.9457 | 11.9457 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
流動資産總額 | 9.14362 | 10.9442 | 11.9112 | 13.468 | 15.6381 |
現金和短期投資 | 9.14362 | 10.9442 | 11.9112 | 13.468 | 15.6381 |
現金 | 9.14362 | 10.9442 | 11.9112 | 13.468 | 15.6381 |
總資産 | 9.14991 | 10.9514 | 11.9193 | 13.477 | 15.648 |
無形資産,淨額 | 0.00629 | 0.0072 | 0.0081 | 0.009 | 0.00991 |
流動負債總額 | 0.29729 | 0.30155 | 0.23558 | 0.26291 | 0.23788 |
Payable/Accrued | 0.2309 | 0.30046 | 0.22085 | 0.22085 | 0.22085 |
預提費用 | 0.06639 | 0.00108 | 0.01473 | 0.04206 | 0.01703 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
負債總額 | 0.29729 | 0.30155 | 0.23558 | 0.26291 | 0.23788 |
長期債務總額 | 0 | 0 | 0 | 0 | 0 |
股權 | 8.85263 | 10.6499 | 11.6837 | 13.2141 | 15.4101 |
普通股 | 0.01285 | 0.01285 | 0.01285 | 0.01285 | 0.01285 |
額外實收資本 | 56.4576 | 55.8631 | 55.2686 | 54.674 | 54.0795 |
留存收益(累計赤字) | -47.6178 | -45.226 | -43.5977 | -41.4728 | -38.6823 |
總負債和股東權益 | 9.14991 | 10.9514 | 11.9193 | 13.477 | 15.648 |
已發行普通股總數 | 12.8482 | 12.8482 | 12.8482 | 12.8482 | 12.8482 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
淨收入/起跑線 | -7.82524 | -4.57058 | -1.86296 | -3.42531 | -1.68966 |
經營活動産生的現金 | -6.20003 | -4.29155 | -1.15296 | -0.29327 | -0.11495 |
Amortization | 0.00361 | 0.00361 | 0.00361 | 0.00361 | 0.00361 |
營運資金的變化 | -0.12227 | -0.38517 | 0.0284 | 2.93349 | 1.5711 |
融資活動産生的現金 | -7.53622 | 2.83544 | 29.8065 | 0.215 | 0.2 |
股票的發行(報廢),淨額 | -7.53622 | 3.1106 | 30.1665 | 0 | 0.1 |
債務的發行(退還),淨額 | 0 | -0.27515 | -0.36 | 0.215 | 0.1 |
現金淨變化 | -13.7362 | -1.45611 | 28.6535 | -0.07827 | 0.08505 |
非現金物品 | 1.74387 | 0.66058 | 0.67799 | 0.19494 | 0 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -2.1249 | -7.82524 | -5.03473 | -2.7157 | -1.96963 |
Cash From Operating Activities | -1.55681 | -6.20003 | -4.02997 | -2.48016 | -1.94746 |
Amortization | 0.0009 | 0.00361 | 0.00271 | 0.00181 | 0.0009 |
Non-Cash Items | 0.59452 | 1.74387 | 1.14934 | 0.38977 | 0.16527 |
Changes in Working Capital | -0.02733 | -0.12227 | -0.14729 | -0.15604 | -0.144 |
Cash From Financing Activities | 0 | -7.53622 | -7.53622 | -7.53622 | -5.51371 |
Issuance (Retirement) of Stock, Net | 0 | -7.53622 | -7.53622 | -7.53622 | -5.51371 |
Issuance (Retirement) of Debt, Net | 0 | 0 | 0 | 0 | |
Net Change in Cash | -1.55681 | -13.7362 | -11.5662 | -10.0164 | -7.46117 |
差價合約交易計算器
計算您的假設損益
交易佣金
0
- 1:1
槓桿
1:1
- 20
- 100
- 500
- 1000
- 10000
交易
交易規模(槓桿 x 投資):
打開
拋售
已賣出 做多
Industry: | Biopharmaceuticals |
3992 Bluebonnet Dr, Building 14
STAFFORD
TEXAS 77477
US
盈虧控制
- Annual
- Quarterly
人們也觀看
還在尋找值得信賴的經紀商?
加入全球 610,000 多名交易者,選擇與 Capital.com 交易